- Home
- / Can-Fite BioPharma
Can-Fite BioPharma
Revenue
$853 K
FY, 2021
Market Capitalization
₪3 B
2023-01-30
Can-Fite BioPharma Summary
Company summary
- Overview
- Can-Fite BioPharma is a biopharmaceutical company with pharmaceutical discovery and clinical development capabilities. It has a pipeline of proprietary compounds that address autoimmune-inflammatory and liver diseases.
- Type
- Public
- Status
- Active
- Founded
- 1994
- HQ
- Petah Tikva, IL | view all locations
- Website
- http://www.canfite.com
- Cybersecurity rating
Key people
Pnina Fishman, Chief Executive Officer, Director
Abraham Sartani, Director
Can-Fite BioPharma Financials
Summary financials
- Revenue (Q3, 2022)
- $204.0K
- Gross profit (Q3, 2022)
- $204.0K
- Net income (Q3, 2022)
- ($2.5M)
- Cash (Q3, 2022)
- $3.7M
- EBIT (Q3, 2022)
- ($2.6M)
- Enterprise value
- $3.0B
Competitors and similar companies
Blogs
Footer menu
Products
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension